Department of Laboratory Medicine, Catholic Blood and Marrow Transplantation Center, The Catholic University of Korea, Seoul, Korea.
Acta Haematol. 2013;129(2):78-82. doi: 10.1159/000342490. Epub 2012 Nov 16.
The ETV6/ABL1 fusion transcript is thought to be a very rare aberration in hematopoietic malignancies. We describe two new cases of acute leukemia with the ETV6/ABL1 fusion, acute myeloid leukemia with eosinophilia (case 1) and B acute lymphoblastic leukemia (ALL) (case 2), screened by multiplex RT-PCR. The ETV6/ABL1 fusion was also confirmed by fluorescence in situ hybridization using a mixture of BCR/ABL1 and ETV6/RUNX1 probes. A thorough review of all published cases showed that all 7 reported ALL patients possess the type A ETV6/ABL1 fusion transcript, composed of the first 4 exons of ETV6 fused to the second exon of ABL1. The presence of the type A fusion transcript strongly implies ALL manifestation in ETV6/ABL1-positive hematologic malignancies as minor BCR breakpoint in BCR/ABL1-positive ALL.
ETV6/ABL1 融合转录本被认为是血液恶性肿瘤中一种非常罕见的异常。我们通过多重 RT-PCR 筛选出了两例新的 ETV6/ABL1 融合急性白血病,伴嗜酸性粒细胞增多的急性髓细胞白血病(病例 1)和 B 型急性淋巴细胞白血病(ALL)(病例 2)。使用 BCR/ABL1 和 ETV6/RUNX1 探针混合物通过荧光原位杂交也证实了 ETV6/ABL1 融合。对所有已发表病例的全面回顾表明,所有 7 例报告的 ALL 患者均具有 A 型 ETV6/ABL1 融合转录本,由 ETV6 的前 4 个外显子与 ABL1 的第二个外显子融合而成。A 型融合转录本的存在强烈提示 ETV6/ABL1 阳性血液恶性肿瘤中 ALL 的表现,就像 BCR/ABL1 阳性 ALL 中的次要 BCR 断点一样。